These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 3771958

  • 41. Theophylline bioavailability in the dog.
    Tse FL, Szeto DW.
    J Pharm Sci; 1982 Nov; 71(11):1301-3. PubMed ID: 7175732
    [Abstract] [Full Text] [Related]

  • 42. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH, Schwabe L, Staib AH, Rietbrock N, Lassmann A, Molz KH, Schuppan D, Siebert-Weigel M, Voegele D.
    Arzneimittelforschung; 1983 Nov; 33(3):446-52. PubMed ID: 6683521
    [Abstract] [Full Text] [Related]

  • 43. In vivo-in vitro correlations with sustained-release theophylline preparations.
    Ritschel WA, Koch HP, Alcorn GJ.
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):609-18. PubMed ID: 6513678
    [Abstract] [Full Text] [Related]

  • 44. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal.
    Lim DT, Singh P, Nourtsis S, Dela Cruz R.
    Ann Emerg Med; 1986 Nov; 15(11):1303-7. PubMed ID: 3777587
    [Abstract] [Full Text] [Related]

  • 45. Clinical pharmacokinetics of amoxycillin and theophylline during cotreatment with both medicaments.
    Jonkman JH, van der Boon WJ, Schoenmaker R, Holtkamp AH, Hempenius J.
    Chemotherapy; 1985 Nov; 31(5):329-35. PubMed ID: 4053732
    [Abstract] [Full Text] [Related]

  • 46. Nonlinear theophylline elimination.
    Tang-Liu DD, Williams RL, Riegelman S.
    Clin Pharmacol Ther; 1982 Mar; 31(3):358-69. PubMed ID: 7060318
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Effect of an antacid on gastrointestinal absorption of theophylline.
    Arnold LA, Spurbeck GH, Shelver WH, Henderson WM.
    Am J Hosp Pharm; 1979 Aug; 36(8):1059-62. PubMed ID: 484565
    [Abstract] [Full Text] [Related]

  • 49. Stability of theophylline elimination rate.
    Milavetz G, Vaughan LM, Weinberger MM.
    Clin Pharmacol Ther; 1987 Apr; 41(4):388-91. PubMed ID: 3549119
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Theophylline kinetics: dose dependency and single sample prediction of clearance.
    Bachmann K, Schwartz J, Forney R, Jauregui L.
    Pharmacology; 1985 Apr; 30(3):136-44. PubMed ID: 3975263
    [Abstract] [Full Text] [Related]

  • 52. [Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children].
    Berdel D, Heimann G.
    Wien Klin Wochenschr; 1984 Aug 31; 96(16):616-21. PubMed ID: 6516414
    [Abstract] [Full Text] [Related]

  • 53. Effect of ethanol on theophylline absorption in humans.
    Koysooko R, Ellis EF, Levy G.
    J Pharm Sci; 1975 Feb 31; 64(2):99-301. PubMed ID: 1127605
    [Abstract] [Full Text] [Related]

  • 54. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
    Karim A, Burns T, Wearley L, Streicher J, Palmer M.
    Clin Pharmacol Ther; 1985 Jul 31; 38(1):77-83. PubMed ID: 4006379
    [Abstract] [Full Text] [Related]

  • 55. Cimetidine decreases theophylline clearance.
    Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R.
    Am Rev Respir Dis; 1981 Jun 31; 123(6):615-7. PubMed ID: 7023306
    [Abstract] [Full Text] [Related]

  • 56. Prediction of theophylline clearance using condition correction factors.
    Haumschild MJ, Murphy JE.
    Clin Pharm; 1985 Jun 31; 4(1):59-64. PubMed ID: 3971684
    [Abstract] [Full Text] [Related]

  • 57. Theophylline product and dosing interval selection for chronic asthma.
    Hendeles L, Weinberger M.
    J Allergy Clin Immunol; 1985 Aug 31; 76(2 Pt 2):285-91. PubMed ID: 4019956
    [Abstract] [Full Text] [Related]

  • 58. Food induced changes in theophylline absorption from a once-a-day theophylline product.
    Steffensen G, Pedersen S.
    Br J Clin Pharmacol; 1986 Nov 31; 22(5):571-7. PubMed ID: 3790404
    [Abstract] [Full Text] [Related]

  • 59. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline.
    Van Aerde P, Moerman E, Van Severen R, Braeckman P.
    Pharmazie; 1984 Mar 31; 39(3):171-2. PubMed ID: 6728890
    [Abstract] [Full Text] [Related]

  • 60. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
    Bialer M, Salame K, Raz I.
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec 31; 23(12):662-7. PubMed ID: 4093206
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.